Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant for mitochondrial dysfunction in hemodialysis
NCT03177798Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2017
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of icatibant in Mitochondriopathy (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Phosphocreatine Recovery Time. Started Aug 2017; status: completed.
02
Drugs
icatibant
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on NCT03177798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177798.